Compugen | CGEN - Ordinary Share Capital


Compugen reported $93.54M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.





Ordinary Share Capital Change Date
Arca Biopharma USD 37K 0 Mar/2025
aTyr Pharma USD 97.99M 97.9M Sep/2025
Bio Path USD 8K 2K Mar/2025
Brainstorm Cell Therapeutics USD 15K 1000 Mar/2025
Cara Therapeutics USD 2K 3K Mar/2025
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 93.54M 3.99M Jun/2025
Immunic USD 8K 4K Jun/2024
Infinity Pharmaceuticals USD 90K 1000 Jun/2023
Minerva Neurosciences USD 1000 0 Sep/2024
RedHill Biopharma USD 33.3B 20.4B Jun/2025
TherapeuticsMD USD 11K 0 Sep/2023